Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma.

Hematology Reports
Stefano LuminariMassimo Federico

Abstract

Since anthracyclines were introduced in the treatment of non-Hodgkin's lymphoma in the late 1960s, they have been acknowledged as a cornerstone in the management of the disease and, in particular, of aggressive lymphomas. The high efficacy of anthracycline-containing regimens must, however, be balanced against the drug-related toxicity, which mainly affects the cardiovascular system and represents a major concern for clinicians, especially in the treatment of elderly patients. Patients' outcomes could be further improved, particularly for those at high risk of cardiotoxicity, by substituting liposomal doxorubicin for conventional doxorubicin. This approach has already been tested and shown to be effective in several cancers, especially in different subsets of patients with diffuse large B-cell lymphoma. The use of liposomal doxorubicin in combination regimens for other conditions, such as follicular lymphoma and splenic marginal zone lymphoma, is also under investigation, and early results are promising.

References

Jun 1, 1989·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M FedericoR L Magin
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 4, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S LimatJ Y Cahn
Oct 18, 2003·Journal of Cancer Research and Clinical Oncology·S M Swain, P Vici
Feb 19, 2005·Seminars in Oncology·Theresa M Allen, Francis J Martin
Feb 19, 2005·Seminars in Oncology·Michael S EwerAlberto A Gabizon
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FeugierB Coiffier
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine Thieblemont, Bertrand Coiffier
Jan 30, 2008·The Lancet Oncology·Michael PfreundschuhUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Apr 22, 2008·The Cochrane Database of Systematic Reviews·E C van DalenL C M Kremer

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01009970
NCT00575406
NCT01148446
NCT00774826

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2021 Meta ULC. All rights reserved